Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,623 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,623 in last 12 months

Showing 87218740 of 13,380 recalls

DrugJuly 11, 2016· Actavis Inc

Recalled Item: Dextroamphetamine Sulfate Extended-Release Capsules Recalled by Actavis Inc...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 5, 2016· Let's Talk Health, Inc.

Recalled Item: Oxygen Nasal Wash (purified water Recalled by Let's Talk Health, Inc. Due to...

The Issue: Marketed Without An Approved NDA/ANDA: product is an unapproved drug due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2016· Actavis Inc

Recalled Item: Glipizide 2.5 mg Extended-release tablets Recalled by Actavis Inc Due to...

The Issue: Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2016· Allergan Sales, LLC

Recalled Item: TAZORAC (tazarotene) Gel 0.05% Recalled by Allergan Sales, LLC Due to Failed...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2016· Allergan Sales, LLC

Recalled Item: TAZORAC (tazarotene) Gel 0.05% Recalled by Allergan Sales, LLC Due to Failed...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 29, 2016· Isomeric Pharmacy Solution, LLC

Recalled Item: Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection Recalled by...

The Issue: Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 28, 2016· Golden State Medical Supply Inc.

Recalled Item: DULOXETINE Delayed-Release Capsules Recalled by Golden State Medical Supply...

The Issue: Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 27, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: Carvediol Tablets Recalled by Sun Pharmaceutical Industries, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 27, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Recalled...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 27, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: Carvediol Tablets Recalled by Sun Pharmaceutical Industries, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 27, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: Carvediol Tablets Recalled by Sun Pharmaceutical Industries, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 27, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: Carvediol Tablets Recalled by Sun Pharmaceutical Industries, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 24, 2016· Teva North America

Recalled Item: Amoxicillin for Oral Suspension USP Recalled by Teva North America Due to...

The Issue: Superpotent drug: Out of specification test result for assay during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 23, 2016· Hospira Inc.

Recalled Item: Diazepam Injection USP 10mg/2mL (5 mg/mL Recalled by Hospira Inc. Due to...

The Issue: Crystallization: Product contains particulate identified to be crystallized...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 22, 2016· Teva North America

Recalled Item: Albuterol Sulfate Syrup Recalled by Teva North America Due to Presence of...

The Issue: Presence of Foreign Substance; presence of black particles describes...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 22, 2016· Mylan Pharmaceuticals Inc.

Recalled Item: Alprazolam Extended-release Tablets Recalled by Mylan Pharmaceuticals Inc....

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 17, 2016· Teva North America

Recalled Item: ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL)...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 17, 2016· Teva North America

Recalled Item: Linezolid Injection 600 mg/300 mL Rx Only Recalled by Teva North America Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 17, 2016· Teva North America

Recalled Item: Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 17, 2016· Teva North America

Recalled Item: Ondansetron Injection USP 40 mg/20 mL (2 mg/mL) Recalled by Teva North...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund